Evidence map›Paper›PMID 37775611›Full record

Trial reportDiabetologia2023

Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.

Merel M Ruissen, José D Torres-Peña, Bas S Uitbeijerse, Antonio P Arenas de Larriva, Sasja D Huisman, Tuncay Namli, Eckhard Salzsieder, Lutz Vogt, Manuela Ploessnig, Bob van der Putte and 8 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03588104 (Evaluation of the POWER2DM Diabetes Self-Management Support System Compared With Usual Care for Patients With Diabetes), which is not on this map. Cited by 27 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 6 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03588104 nacompletednot on this map

Evaluation of the POWER2DM Diabetes Self-Management Support System Compared With Usual Care for Patients With Diabetes

TypeinterventionalSponsorLeiden University Medical CenterRan2018 to 2020Enrolled222ConditionsType1 Diabetes Mellitus, Type2 Diabetes Mellitus, Diabetes Mellitus, Health BehaviorArmsPOWER2DM system, Usual care
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 6 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. An Apple-watch all day keeps your life astray-or does it?Scandinavian journal of public health · 2026
    Article
  11. Observational
  12. Article
  13. Barriers and enablers for health system reform.Frontiers in health services · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Dynamics and determinants of long-term quality of life in children and adolescents with type 1 diabetes: real-world evidence from China.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Merel M RuissenDepartment of Medicine, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-5720-0674
José D Torres-PeñaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Córdoba, Spain.ORCID http://orcid.org/0000-0001-9475-8952
Bas S UitbeijerseDepartment of Medicine, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0003-4574-6722
Antonio P Arenas de LarrivaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Córdoba, Spain.ORCID http://orcid.org/0000-0001-8897-5176
Sasja D HuismanDepartment of Medicine, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-9176-9215
Tuncay NamliSRDC Software Research & Development and Consultancy Corp., Ankara, Turkey.ORCID http://orcid.org/0000-0003-1157-8994
Eckhard SalzsiederInstitute of Diabetes 'Gerhardt Katsch', Karlsburg, Germany.ORCID http://orcid.org/0000-0002-1078-2347
Lutz VogtDiabetes Service Center GmbH, Karlsburg, Germany.ORCID http://orcid.org/0000-0002-9676-8895
Manuela PloessnigSalzburg Research Forschungsgesellschaft, Salzburg, Austria.ORCID http://orcid.org/0000-0002-8191-612X
Bob van der PuttePrimedata, Delft, the Netherlands.
Armelle MerleiHealthLabs Europe, Paris, France.
Gustavo SerraiHealthLabs Europe, Paris, France.
Gustavo RodrígueziHealthLabs Europe, Paris, France.
Albert A de GraafNetherlands Organization for Applied Scientific Research (TNO), Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-1067-3570
Eelco J P de KoningDepartment of Medicine, Leiden University Medical Center, Leiden, the Netherlands. e.j.p.de_koning@lumc.nl.ORCID http://orcid.org/0000-0002-1232-7022
Javier Delgado-Lista *Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Córdoba, Spain.ORCID http://orcid.org/0000-0002-2982-2716
Jacob K Sont *Department of Biomedical Data Sciences, Medical Decision Making Section, Leiden University Medical Center, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-5840-0651
POWER2DM Consortium
Leiden University Medical Center · NLInstituto de Salud Carlos III · ESInstitute for Diabetes Gerhardt Katsch · DENetherlands Organisation for Applied Scientific Research · NLSoftware Research and Development Consulting · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThere is a lack of e-health systems that integrate the complex variety of aspects relevant for diabetes self-management. We developed and field-tested an e-health system (POWER2DM) that integrates medical, psychological and behavioural aspects and connected wearables to support patients and healthcare professionals in shared decision making and diabetes self-management.

methodsParticipants with type 1 or type 2 diabetes (aged >18 years) from hospital outpatient diabetes clinics in the Netherlands and Spain were randomised using randomisation software to POWER2DM or usual care for 37 weeks. This RCT assessed the change in HbA

resultsA total of 226 participants participated in the trial (108 with type 1 diabetes; 118 with type 2 diabetes). In the POWER2DM group (n=111), HbA CONCLUSIONS/

interpretationPOWER2DM improves HbA

trial registrationClinicalTrials.gov NCT03588104.

fundingThis study was funded by the European Union's Horizon 2020 Research and Innovation Programme (grant agreement number 689444).

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HypoglycemiaSelf-ManagementTelemedicineBlood GlucoseBlood Glucose Self-MonitoringDecision Making, SharedHumansHypoglycemic AgentsQuality of LifeBlood GlucoseHypoglycemic AgentsDiabetese-healthGlycaemic controlm-healthQuality of lifeRCTSelf-managementShared decision making

Identifiers

PMID37775611
PMCPMC10627940
OpenAlexW4387164290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.